(RBBN) Ribbon Communications - Overview
Stock: Session Border Controllers, Media Gateways, Optical Transport, 5G Core
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 58.7% |
| Relative Tail Risk | -19.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.05 |
| Alpha | -72.89 |
| Character TTM | |
|---|---|
| Beta | 1.339 |
| Beta Downside | 1.510 |
| Drawdowns 3y | |
|---|---|
| Max DD | 61.87% |
| CAGR/Max DD | -0.29 |
Description: RBBN Ribbon Communications December 25, 2025
Ribbon Communications (NASDAQ:RBBN) delivers communications-technology solutions across North America, Europe, the Middle East, Africa, and the Asia-Pacific, operating through two primary segments: Cloud & Edge and IP Optical Networks.
The Cloud & Edge segment supplies software and hardware for VoIP, VoLTE, and Vo5G, as well as unified communications, session border controllers, and network-transformation tools that run on private, public, hybrid clouds, data-center, enterprise, and service-provider environments.
The IP Optical Networks segment focuses on routing, switching, and optical-transport hardware and software that underpin 5G-native mobile back-haul, metro-edge aggregation, core networking, and data-center interconnect for carriers, utilities, government, defense, finance, transportation, and research institutions.
Key recent metrics: FY 2023 revenue of roughly $1.3 billion, an adjusted EBITDA margin near 10 %, and a cash balance of about $300 million-figures that reflect ongoing 5G rollout spending, the shift toward virtualized network functions, and heightened capex in edge-computing infrastructure. The broader communications-equipment sector is being driven by carrier upgrades to 5G, increasing demand for cloud-native solutions, and macro-level telecom-capex growth projected at 5-6 % annually through 2027.
For a deeper quantitative view of Ribbon’s valuation metrics, you might explore the company’s profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: -43.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 5.58 > 1.0 |
| NWC/Revenue: 14.57% < 20% (prev 15.26%; Δ -0.69% < -1%) |
| CFO/TA 0.08 > 3% & CFO 83.9m > Net Income -43.1m |
| Net Debt (333.4m) to EBITDA (70.1m): 4.76 < 3 |
| Current Ratio: 1.43 > 1.5 & < 3 |
| Outstanding Shares: last quarter (176.4m) vs 12m ago 1.00% < -2% |
| Gross Margin: 50.62% > 18% (prev 0.50%; Δ 5013 % > 0.5%) |
| Asset Turnover: 78.25% > 50% (prev 72.56%; Δ 5.69% > 0%) |
| Interest Coverage Ratio: 0.20 > 6 (EBITDA TTM 70.1m / Interest Expense TTM 45.8m) |
Altman Z'' -6.26
| A: 0.11 (Total Current Assets 418.4m - Total Current Liabilities 291.9m) / Total Assets 1.11b |
| B: -1.47 (Retained Earnings -1.62b / Total Assets 1.11b) |
| C: 0.01 (EBIT TTM 8.96m / Avg Total Assets 1.11b) |
| D: -2.17 (Book Value of Equity -1.62b / Total Liabilities 745.2m) |
| Altman-Z'' Score: -6.26 = D |
Beneish M -3.30
| DSRI: 0.82 (Receivables 218.3m/249.2m, Revenue 868.6m/808.9m) |
| GMI: 0.98 (GM 50.62% / 49.58%) |
| AQI: 0.93 (AQ_t 0.52 / AQ_t-1 0.55) |
| SGI: 1.07 (Revenue 868.6m / 808.9m) |
| TATA: -0.11 (NI -43.1m - CFO 83.9m) / TA 1.11b) |
| Beneish M-Score: -3.30 (Cap -4..+1) = AA |
What is the price of RBBN shares?
Over the past week, the price has changed by -25.19%, over one month by -30.74%, over three months by -37.97% and over the past year by -53.22%.
Is RBBN a buy, sell or hold?
- StrongBuy: 4
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the RBBN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 5.8 | 193.4% |
| Analysts Target Price | 5.8 | 193.4% |
| ValueRay Target Price | 2.5 | 29.6% |
RBBN Fundamental Data Overview February 04, 2026
P/B = 1.2851
Revenue TTM = 868.6m USD
EBIT TTM = 8.96m USD
EBITDA TTM = 70.1m USD
Long Term Debt = 326.1m USD (from longTermDebt, last quarter)
Short Term Debt = 20.4m USD (from shortTermDebt, last quarter)
Debt = 408.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 333.4m USD (from netDebt column, last quarter)
Enterprise Value = 822.2m USD (488.7m + Debt 408.2m - CCE 74.8m)
Interest Coverage Ratio = 0.20 (Ebit TTM 8.96m / Interest Expense TTM 45.8m)
EV/FCF = 15.64x (Enterprise Value 822.2m / FCF TTM 52.6m)
FCF Yield = 6.40% (FCF TTM 52.6m / Enterprise Value 822.2m)
FCF Margin = 6.05% (FCF TTM 52.6m / Revenue TTM 868.6m)
Net Margin = -4.96% (Net Income TTM -43.1m / Revenue TTM 868.6m)
Gross Margin = 50.62% ((Revenue TTM 868.6m - Cost of Revenue TTM 428.9m) / Revenue TTM)
Gross Margin QoQ = 50.13% (prev 49.55%)
Tobins Q-Ratio = 0.74 (Enterprise Value 822.2m / Total Assets 1.11b)
Interest Expense / Debt = 2.84% (Interest Expense 11.6m / Debt 408.2m)
Taxrate = 21.0% (US default 21%)
NOPAT = 7.08m (EBIT 8.96m * (1 - 21.00%))
Current Ratio = 1.43 (Total Current Assets 418.4m / Total Current Liabilities 291.9m)
Debt / Equity = 1.13 (Debt 408.2m / totalStockholderEquity, last quarter 360.1m)
Debt / EBITDA = 4.76 (Net Debt 333.4m / EBITDA 70.1m)
Debt / FCF = 6.34 (Net Debt 333.4m / FCF TTM 52.6m)
Total Stockholder Equity = 379.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -3.88% (Net Income -43.1m / Total Assets 1.11b)
RoE = -11.36% (Net Income TTM -43.1m / Total Stockholder Equity 379.2m)
RoCE = 1.27% (EBIT 8.96m / Capital Employed (Equity 379.2m + L.T.Debt 326.1m))
RoIC = 0.99% (NOPAT 7.08m / Invested Capital 715.4m)
WACC = 6.93% (E(488.7m)/V(897.0m) * Re(10.85%) + D(408.2m)/V(897.0m) * Rd(2.84%) * (1-Tc(0.21)))
Discount Rate = 10.85% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.97%
[DCF Debug] Terminal Value 75.36% ; FCFF base≈52.6m ; Y1≈34.5m ; Y5≈15.7m
Fair Price DCF = 0.27 (EV 381.3m - Net Debt 333.4m = Equity 47.8m / Shares 176.6m; r=6.93% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 16.38 | EPS CAGR: 112.9% | SUE: -4.0 | # QB: 0
Revenue Correlation: 10.26 | Revenue CAGR: -1.80% | SUE: -0.53 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.01 | Chg30d=-0.021 | Revisions Net=-1 | Analysts=5
EPS next Year (2026-12-31): EPS=0.27 | Chg30d=-0.063 | Revisions Net=-2 | Growth EPS=+57.7% | Growth Revenue=+5.7%